Delivery Order SPE2DB22D1200-SPE2DB25FN4BB
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,856.42 for Fenofibrate 40 mg tablets (90-count supply) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Fenofibrate 145 mg tablets in quantities of 90 units, with a ceiling value of $24,586.18. This is a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Fenofibrate 145 mg tablets (90-count packages) with a ceiling value of $59,272.53 and a firm fixed price structure. The contract is set to reach ultimate completion by September 17, 2025, and represents a delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Fenofibrate 120 mg tablets (90-count package) under a firm fixed-price contract with a ceiling value of $2,373.85. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Fenofibrate 145 mg tablets in a quantity of 500 units. This firm fixed-price delivery order, valued at approximately $20,800, represents a non-set-aside competitive award to support federal medical procurement needs. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $39,887.11 firm fixed price delivery order to AmerisourceBergen Drug Corp for Fenofibrate 145 mg tablets (90-count supply) with an ultimate completion date of June 3, 2025. This non-set-aside award was competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract relationship with the DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Fenofibrate 150 mg capsules (90-count units) with a ceiling value of $20,355.54. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 29, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As...
- This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Fenofibrate 145 mg tablets, a cardiovascular medication, valued at $10,512.99 with a completion date of September 26, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,277.62 delivery order is for the supply of Fenofibrate 48 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The contract has a firm fixed price and an ultimate completion date of June 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $34,874.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 bottles of 145 mg fenofibrate tablets. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is July 7-10, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this order for a common cholesterol medication supports the Agency's mission to provide logistical support for all military...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN4BBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,832.85 to AmerisourceBergen Drug Corp for the supply of Fenofibrate 145 mg tablets (90-count units) on August 26, 2025, with completion scheduled for August 27, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages this prime IDC to supply a broad spectrum of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling medical procurement requirements across multiple therapeutic domains, including specialty medications, generic drugs, vaccines, and specialized medical supplies. This particular delivery order for Fenofibrate, a commonly prescribed cardiovascular medication, reflects the routine pharmaceutical supply operations conducted under the broader strategic framework of DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 8/26/25 |